BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30834459)

  • 61. Confirming an expanded spectrum of SCN2A mutations: a case series.
    Matalon D; Goldberg E; Medne L; Marsh ED
    Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mutation screening of the PRRT2 gene for benign epilepsy with centrotemporal spikes in Chinese mainland population.
    Che XQ; Sun ZF; Mao X; Xia K; Yan XX; Jiang H; Shen L; Li N; Tang BS
    Int J Neurosci; 2017 Jan; 127(1):10-13. PubMed ID: 26954261
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?
    Scheffer IE; Zhang YH; Jansen FE; Dibbens L
    Brain Dev; 2009 May; 31(5):394-400. PubMed ID: 19203856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 65. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2.
    Ishii A; Miyajima T; Kurahashi H; Wang JW; Yasumoto S; Kaneko S; Hirose S
    Epilepsy Res; 2012 Nov; 102(1-2):122-5. PubMed ID: 22884718
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.
    Drenth JP; te Morsche RH; Guillet G; Taieb A; Kirby RL; Jansen JB
    J Invest Dermatol; 2005 Jun; 124(6):1333-8. PubMed ID: 15955112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biallelic truncating SCN9A mutation identified in four families with congenital insensitivity to pain from Pakistan.
    Sawal HA; Harripaul R; Mikhailov A; Dad R; Ayub M; Jawad Hassan M; Vincent JB
    Clin Genet; 2016 Dec; 90(6):563-565. PubMed ID: 27747863
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dravet syndrome and its mimics: Beyond SCN1A.
    Steel D; Symonds JD; Zuberi SM; Brunklaus A
    Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Progress in unraveling the genetic etiology of rolandic epilepsy.
    Xiong W; Zhou D
    Seizure; 2017 Apr; 47():99-104. PubMed ID: 28351718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Child with atypical partial Rolandic epilepsy].
    Rudenko AIu; Svystil'nyk VO; Konoplianko TV
    Lik Sprava; 2004; (1):54-5. PubMed ID: 17051716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Seizure in benign epilepsy with centro-temporal spikes.
    Kanabar G; Sully M; Walsh K; Chawla K
    Epileptic Disord; 2010 Dec; 12(4):306-8. PubMed ID: 21112828
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SCN1A clinical spectrum includes the self-limited focal epilepsies of childhood.
    Kivity S; Oliver KL; Afawi Z; Damiano JA; Arsov T; Bahlo M; Berkovic SF
    Epilepsy Res; 2017 Mar; 131():9-14. PubMed ID: 28192756
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
    Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
    Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidental rolandic spikes: long-term outcomes and impact of treatment.
    McNally MA; Kossoff EH
    Epilepsy Behav; 2015 Feb; 43():135-8. PubMed ID: 25623811
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Children with Rolandic spikes and ictal vomiting: Rolandic epilepsy or Panayiotopoulos syndrome?
    Covanis A; Lada C; Skiadas K
    Epileptic Disord; 2003 Sep; 5(3):139-43. PubMed ID: 14684348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Scn1a dysfunction alters behavior but not the effect of stress on seizure response.
    Sawyer NT; Helvig AW; Makinson CD; Decker MJ; Neigh GN; Escayg A
    Genes Brain Behav; 2016 Mar; 15(3):335-47. PubMed ID: 26694226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
    de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
    Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sudden unexpected death in GEFS+ families with sodium channel pathogenic variants.
    Myers KA; Shevell MI; Sébire G
    Epilepsy Res; 2019 Feb; 150():66-69. PubMed ID: 30660056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Benign rolandic epilepsy and generalized paroxysms: A study of 13 patients.
    Vargas R; Beltrán L; Lizama R; Valenzuela GR; Caraballo R
    Seizure; 2018 Apr; 57():27-31. PubMed ID: 29547828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.